Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis
| Autor: | Daniel McNicholas, Jody Khan, James C. Forde, Usman M Haroon, Niall F. Davis, Richard E. Power |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Urology General Medicine Perioperative 030204 cardiovascular system & hematology Hyperplasia medicine.disease 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Quality of life Prostate Lower urinary tract symptoms medicine Cost analysis International Prostate Symptom Score 030212 general & internal medicine business Transurethral resection of the prostate |
| Zdroj: | Irish Journal of Medical Science (1971 -). 191:421-426 |
| ISSN: | 1863-4362 0021-1265 |
| DOI: | 10.1007/s11845-021-02552-z |
| Popis: | Rezum technology uses heat from radiofrequency-generated water vapour to ablate prostate tissue. We evaluate the introduction of this thermal therapy to an Irish teaching hospital for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. A pilot study of men with moderate to severe lower urinary tract symptoms who underwent Rezum treatment to the prostate was performed. Perioperative efficacy was evaluated using international prostate symptom score (IPSS), quality of life score (IPSS-QOL), uroflowmetry and post-void residual (PVR) volumes. Costs were evaluated and compared against matched patients undergoing the standard of care, transurethral resection of the prostate (TURP). Ten patients with a mean age of 70 ± 9 years who met the inclusion criteria underwent Rezum treatment. Mean PSA was 4.73 ± 4 ng/mL and mean prostate volume 72 ± 30 cc. Rezum therapy significantly improved both IPSS by 74% from mean baseline score of 20.8 ± 4 to 5.3 ± 1.49 (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink